Prof. bernard Martel (University of Lille, France) showed how the new cyclodextrin-based mask was developed from the in-lab optimization to
The patent application (1) with priority date of 09. March 2020 claims that methyl bCD preferably with DS 0.7 (Crysmeb)
A recent review of Jicsinszky et al. (2021) gave an overview on cyclodextrins’ benefits and limitations in various antiviral drug
This review discusses the basic properties of the different cyclodextrin derivatives, their potential in antiviral formulations, and the prevention and
Science News reported that a combination of remdesivir, a drug formulated by SBECD and currently approved in the United States
Vitamin D deficiency or insufficiency is very common in the general population as well as in patients with COVID-19. It
Nanotechnology has emerged as one of the most promising technologies on account of its ability to deal with viral diseases
Making a comparison between CDs and the unique Ring of the legendary novel of The Lord of the Rings, J.